Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387145655> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4387145655 abstract "Almost 25,000 new cases of epithelial ovarian cancer (EOC) are reported each year in the United States. Cancers of the ovary have poor prognosis due to drug resistance and metastasis, and have the highest mortality rate of all the known gynecological malignancies. Despite concerted efforts to develop new strategies for preventing and treating ovarian cancer, novel and more effective non-toxic therapies for ovarian cancer are urgently needed. Recent observations show that RO 48-8071 ([4’-[6-(Allylmethylamino)hexyloxy]-4-bromo-2’-fluorobenzophenone fumarate] [RO], a small-molecule inhibitor of the key cholesterol biosynthesis enzyme 2, 3-oxidosqualene cyclase, inhibits breast and prostate cancer cells. RO also induces the tumor-suppressor protein estrogen receptor (ER) β in both breast- and prostate-cancer cells, and also inhibits growth of ovarian-cancer cells both in vitro and in vivo. Extending upon these earlier studies, here we found that RO also induces ERβ expression in OVCAR-3 ovarian-cancer cells. Further, we demonstrated that treatment of two ovarian-cancer cell lines (OVCAR-3 and SK-OV-3) with liquiritigenin (LQ), a naturally occurring compound that is an ERβ agonist, reduced cell viability in vitro. When we treated OVCAR-3 and SK-OV-3 cells with RO, LQ, or RO + LQ, we observed that RO + LQ combination treatment synergistically reduced cell viability. Further in vivo studies examining the effects of RO + LQ combination treatment on EOC are warranted, as a means of exploring a potential new therapeutic approach to combat ovarian cancers with minimal toxicity." @default.
- W4387145655 created "2023-09-29" @default.
- W4387145655 creator A5026893077 @default.
- W4387145655 creator A5040985806 @default.
- W4387145655 date "2023-01-01" @default.
- W4387145655 modified "2023-10-18" @default.
- W4387145655 title "Liquiritigenin Enhances the Inhibitory Effects of the Cholesterol Biosynthesis Inhibitor RO 48-8071 on Cell Viability in Ovarian-Cancer Cells in Vitro" @default.
- W4387145655 doi "https://doi.org/10.26502/jcsct.5079207" @default.
- W4387145655 hasPublicationYear "2023" @default.
- W4387145655 type Work @default.
- W4387145655 citedByCount "0" @default.
- W4387145655 crossrefType "journal-article" @default.
- W4387145655 hasAuthorship W4387145655A5026893077 @default.
- W4387145655 hasAuthorship W4387145655A5040985806 @default.
- W4387145655 hasBestOaLocation W43871456551 @default.
- W4387145655 hasConcept C121608353 @default.
- W4387145655 hasConcept C126322002 @default.
- W4387145655 hasConcept C150903083 @default.
- W4387145655 hasConcept C202751555 @default.
- W4387145655 hasConcept C207001950 @default.
- W4387145655 hasConcept C2780192828 @default.
- W4387145655 hasConcept C2780427987 @default.
- W4387145655 hasConcept C502942594 @default.
- W4387145655 hasConcept C530470458 @default.
- W4387145655 hasConcept C53227056 @default.
- W4387145655 hasConcept C55493867 @default.
- W4387145655 hasConcept C71924100 @default.
- W4387145655 hasConcept C84606932 @default.
- W4387145655 hasConcept C86803240 @default.
- W4387145655 hasConcept C96232424 @default.
- W4387145655 hasConceptScore W4387145655C121608353 @default.
- W4387145655 hasConceptScore W4387145655C126322002 @default.
- W4387145655 hasConceptScore W4387145655C150903083 @default.
- W4387145655 hasConceptScore W4387145655C202751555 @default.
- W4387145655 hasConceptScore W4387145655C207001950 @default.
- W4387145655 hasConceptScore W4387145655C2780192828 @default.
- W4387145655 hasConceptScore W4387145655C2780427987 @default.
- W4387145655 hasConceptScore W4387145655C502942594 @default.
- W4387145655 hasConceptScore W4387145655C530470458 @default.
- W4387145655 hasConceptScore W4387145655C53227056 @default.
- W4387145655 hasConceptScore W4387145655C55493867 @default.
- W4387145655 hasConceptScore W4387145655C71924100 @default.
- W4387145655 hasConceptScore W4387145655C84606932 @default.
- W4387145655 hasConceptScore W4387145655C86803240 @default.
- W4387145655 hasConceptScore W4387145655C96232424 @default.
- W4387145655 hasIssue "03" @default.
- W4387145655 hasLocation W43871456551 @default.
- W4387145655 hasOpenAccess W4387145655 @default.
- W4387145655 hasPrimaryLocation W43871456551 @default.
- W4387145655 hasRelatedWork W2138350991 @default.
- W4387145655 hasRelatedWork W2378785636 @default.
- W4387145655 hasRelatedWork W2409285845 @default.
- W4387145655 hasRelatedWork W2434195791 @default.
- W4387145655 hasRelatedWork W2763585477 @default.
- W4387145655 hasRelatedWork W2794532950 @default.
- W4387145655 hasRelatedWork W2909992919 @default.
- W4387145655 hasRelatedWork W3160990505 @default.
- W4387145655 hasRelatedWork W4304116770 @default.
- W4387145655 hasRelatedWork W4382726614 @default.
- W4387145655 hasVolume "07" @default.
- W4387145655 isParatext "false" @default.
- W4387145655 isRetracted "false" @default.
- W4387145655 workType "article" @default.